PENG ZHU
No ORCID on file
· 16 papers in corpus
· active 2008
Frequent coauthors
- JING JIANG 16
- WU LIU 16
- XINGHONG LUO 16
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…